Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 07 Jan 2026 for AN2 Therapeutics, Inc., €3,088. Read the official filing
Filing timeline
BuySaleStephen David Prior
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Stephen David Prior: trading record in brief
All filings by Stephen David Prior on record concern AN2 Therapeutics, Inc. Between 4 November 2024 and 5 January 2026, the trades on record add up to 5 filings.
The open-market record consists of 3 sales worth €6,495, with no purchase. Besides market trades, the filings include 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 7 January 2026 with an open-market sale (€3,088) in AN2 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen David Prior
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,604 shares@ US$1.00347.5% of flowCommon StockSEC:0001193125-26-006770:0
765 shares@ US$1.1411.7% of flowCommon StockSEC:0001193125-25-270252:0
28,000 shares0Common StockSEC:0000950170-25-030032:0
2,029 shares@ US$1.34140.8% of flowCommon StockSEC:0000950170-25-003153:0
10,125 shares0Common StockSEC:0000950170-24-121601:0
5 of 5 declarations
